This week on two blocks from the White House.

We're talking about our recent travels and what we've learned from them.

I just got back from the Middle East after covering the Iran War.

And I took what felt like the shortest trip to France ever,

accompanying Secretary of State Marco Rubio to the G7 Foreign Ministers meeting on Friday.

And I'm in Florida this week for the Artemis II Space Lunch.

Join me, Katie Simpson and my fellow Washington correspondents, Paul Hunter and Willie Lowry,

every week on two blocks from the White House.

This is a CBC podcast.

And we're sitting up here yeah, we go to the kids, and all in our heads, too.

We go to the kids, yeah, all in our head is to.

We go to the things, get all in a head, still.

We go to the things there.

And we're not, yeah. We go to please conversation. We are joined by Dr. David Hammond, who is a professor, and university research chair in public health in the school of public health

and health systems at the University of Waterloo. And today, I believe, we're going to be diving

into the world of e-cigarettes and vaping and smoking. Yeah, we, I came to this, I came to this, what sort of the context of how we kind of rolled

around and wanted to dive into this, have this conversation was, it was a week or two ago,

I saw in, in some financial news that I was reading that the FDA was approaching a decision on or

was about to to to determine their ruling on a on on on basically a some a piece where they had

requested from any from any business that sells vaping products

in the U.S. to submit proof that or evidence that supports the idea that vaping was a safer

a safer alternative to smoking to to smoking cigarettes, like combustible tobacco,

...